Download PDF
Semin Liver Dis 2012; 32(02): 186-192
DOI: 10.1055/s-0032-1316470
Diagnostic Problems in Hepatology
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatocellular Carcinoma in a Noncirrhotic Patient with HIV: A Case Report and Review of the Literature

Neil Parikh
1   Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY
,
Valerie Martel-Laferriere
1   Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY
,
Xuchen Zhang
2   The Lillian and Henry M. Stratton – Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, NY
,
Douglas Dieterich
1   Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY
,
Maria Isabel Fiel
2   The Lillian and Henry M. Stratton – Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, NY
,
Ponni Perumalswami
1   Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2012 (online)

    Permissions and Reprints

Abstract

A 59-year-old man with human immunodeficiency virus (HIV) was referred for persistently elevated liver enzyme activities. His HIV was well controlled on antiretroviral therapy and his viral load was undetectable. He had no history of chronic liver disease and had minimal alcohol intake. He was asymptomatic and his physical exam was unremarkable without any stigmata of liver disease. Beyond the elevations in alkaline phosphatase and gamma-glutamyl transferase, the rest of his laboratory work, including viral hepatitis serologies and serum α-fetoprotein, was within normal limits. A computed tomography (CT) scan revealed a mildly nodular liver but hepatic mass or ascites was not seen. He was subsequently followed every 3 to 6 months without any change in his clinical symptoms, laboratory values, or imaging tests. Two years after the original visit, the patient presented with acute onset of abdominal pain, an AFP of 15.8 ng/mL, and a 9-cm hepatic mass on imaging. Given his preserved liver function, he underwent right hepatic lobectomy. Histologic examination of the resected tissue was consistent with hepatocellular carcinoma (HCC). The uninvolved liver was noncirrhotic and unremarkable except for mild portal inflammation. As the vast majority of HIV patients who develop HCC have established chronic liver diseases such as hepatitis B and/or C along with cirrhosis, this case of HCC in an HIV patient without cirrhosis or viral hepatitis is rare. Although current screening guidelines recommend imaging only for patients with HIV and hepatitis B/C cirrhosis, closer monitoring may be important in HIV patients with even subtle liver dysfunction.

Keywords

human immunodeficiency virus - hepatocellular carcinoma - hepatitis B virus - hepatitis C virus - noncirrhotic liver
 

  • References

  • 1 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55 (2) 74-108
    Google Scholar
  • 2 Rosenthal E, Poirée M, Pradier C , et al; GERMIVIC Joint Study Group. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003; 17 (12) 1803-1809
    CrossrefPubMedGoogle Scholar
  • 3 Brau N, Fox RK, Xiao P , et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A US-Canadian multicenter study. J Hepatol 2007; 47: 527-537
    CrossrefPubMedGoogle Scholar
  • 4 Sulkowski M. Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness. J Hepatol 2009; 50 (4) 655-658
    PubMedGoogle Scholar
  • 5 Toyoda H, Kumada T, Tokuda A , et al; Yon-Ken HCV-HCC Follow-up Study Group. Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C. J Viral Hepat 2000; 7 (6) 414-419
    CrossrefPubMedGoogle Scholar
  • 6 Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004; 139 (3) 320-325 , discussion 326
    CrossrefPubMedGoogle Scholar
  • 7 Okuda K, Nakashima T, Sakamoto K , et al. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers. Cancer 1982; 49 (3) 450-455
    CrossrefPubMedGoogle Scholar
  • 8 Kumar M, Kumar R, Hissar SS , et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22 (7) 1104-1111
    CrossrefPubMedGoogle Scholar
  • 9 Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996; 105 (1) 65-75
    CrossrefPubMedGoogle Scholar
  • 10 Chen MF, Tsai HP, Jeng LB , et al. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003; 27 (4) 443-447
    CrossrefPubMedGoogle Scholar
  • 11 Pollicino T, Squadrito G, Cerenzia G , et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126 (1) 102-110
    CrossrefPubMedGoogle Scholar
  • 12 Shiota G, Oyama K, Udagawa A , et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62 (2) 151-158
    CrossrefPubMedGoogle Scholar
  • 13 Liu CJ, Chen BF, Chen PJ , et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 2006; 194 (5) 594-599
    CrossrefPubMedGoogle Scholar
  • 14 Yuen MF, Tanaka Y, Shinkai N , et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter and HBV DNA levels. Gut 2008; 57 (1) 98-102
    PubMedGoogle Scholar
  • 15 Guo X, Jin Y, Qian G, Tu H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008; 49 (5) 718-725
    CrossrefPubMedGoogle Scholar
  • 16 Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006; 35 (1) 14-20
    CrossrefPubMedGoogle Scholar
  • 17 Okuda K, Nakashima T, Kojiro M, Kondo Y, Wada K. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology 1989; 97 (1) 140-146
    PubMedGoogle Scholar
  • 18 Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4 (2) 136-146
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Trevisani F, D'Intino PE, Caraceni P , et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995; 75 (9) 2220-2232
    CrossrefPubMedGoogle Scholar
  • 20 Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996; 105 (1) 65-75
    CrossrefPubMedGoogle Scholar
  • 21 Stroffolini T, Andreone P, Andriulli A , et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998; 29 (6) 944-952
    CrossrefPubMedGoogle Scholar
  • 22 Borie F, Bouvier AM, Herrero A , et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008; 98 (7) 505-509
    CrossrefPubMedGoogle Scholar
  • 23 Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42 (5) 341-347
    CrossrefPubMedGoogle Scholar
  • 24 De Mitri MS, Poussin K, Baccarini P , et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345 (8947) 413-415
    CrossrefPubMedGoogle Scholar
  • 25 Makiyama A, Itoh Y, Kasahara A , et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 2004; 101 (7) 1616-1622
    CrossrefPubMedGoogle Scholar
  • 26 Ikeda M, Fujiyama S, Tanaka M , et al. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol 2005; 40 (2) 148-156
    CrossrefPubMedGoogle Scholar
  • 27 Germani G, Hytiroglou P, Fotiadu A, Burroughs AK, Dhillon AP. Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis 2011; 31 (1) 82-90
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Qian GS, Ross RK, Yu MC , et al. A follow-up study of urinary markers of alfatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 3-10
    PubMedGoogle Scholar
  • 29 Bralet MP, Pichard V, Ferry N. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology 2002; 36 (3) 623-630
    CrossrefPubMedGoogle Scholar
  • 30 Kew MD. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic patients. Hepatology 1990; 11: 1086-1087
    CrossrefPubMedGoogle Scholar
  • 31 Deugnier YM, Guyader D, Crantock L , et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993; 104 (1) 228-234
    PubMedGoogle Scholar
  • 32 Zhou H, Fischer HP. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol 1998; 22 (6) 742-748
    CrossrefPubMedGoogle Scholar
  • 33 Conti JA, Kemeny N. Type Ia glycogenosis associated with hepatocellular carcinoma. Cancer 1992; 69 (6) 1320-1322
    CrossrefPubMedGoogle Scholar
  • 34 Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 1993; 152 (Suppl 1) S63-S70
    CrossrefPubMedGoogle Scholar
  • 35 Neuberger J, Forman D, Doll R, Williams R. Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed) 1986; 292 (6532) 1355-1357
    CrossrefPubMedGoogle Scholar
  • 36 Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed) 1986; 292 (6532) 1357-1361
    CrossrefPubMedGoogle Scholar
  • 37 Rooks JB, Ory HW, Ishak KG , et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242 (7) 644-648
    CrossrefPubMedGoogle Scholar
  • 38 Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004; 77 (3) 257-267
    CrossrefPubMedGoogle Scholar
  • 39 Trevisani F, D'Intino PE, Caraceni P , et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995; 75 (9) 2220-2232
    CrossrefPubMedGoogle Scholar
  • 40 Smalley SR, Moertel CG, Hilton JF , et al. Hepatoma in the noncirrhotic liver. Cancer 1988; 62 (7) 1414-1424
    CrossrefPubMedGoogle Scholar
  • 41 Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF. Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg 2008; 25 (5) 376-382
    CrossrefPubMedGoogle Scholar
  • 42 Capussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients—no mortality and long-term survival. Hepatogastroenterology 2006; 53 (71) 768-772
    PubMedGoogle Scholar
  • 43 Calvet X, Bruix J, Brú C , et al. Natural history of hepatocellular carcinoma in Spain. J Hepatol 1990; 10 (3) 311-317
    CrossrefPubMedGoogle Scholar
  • 44 McGinnis KA, Fultz SL, Skanderson M, Conigliaro J, Bryant K, Justice AC. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol 2006; 24 (31) 5005-5009
    CrossrefPubMedGoogle Scholar
  • 45 Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992–2001. Arch Intern Med 2004; 164 (21) 2349-2354
    CrossrefPubMedGoogle Scholar
  • 46 Murillas J, Del Río M, Riera M , et al. Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients. Eur J Intern Med 2005; 16 (2) 113-115
    CrossrefPubMedGoogle Scholar
  • 47 Phillips AA, Justman JE. Screening HIV-infected patients for non-AIDS-defining malignancies. Curr HIV/AIDS Rep 2009; 6 (2) 83-92
    CrossrefPubMedGoogle Scholar
  • 48 Loko MA, Salmon D, Carrieri P , et al; ANRS CO 13 HEPAVIH Study Group. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis 2010; 10: 303
    CrossrefPubMedGoogle Scholar
  • 49 Bruyand M, Dabis F, Vandenhende MA , et al. HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008. J Hepatol 2011; 55 (5) 1058-1062
    CrossrefPubMedGoogle Scholar
  • 50 Puoti M, Bruno R, Soriano V , et al; HIV HCC Cooperative Italian-Spanish Group. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18 (17) 2285-2293
    CrossrefPubMedGoogle Scholar
  • 51 Bourcier V, Winnock M, Ait Ahmed M , et al. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepahiv and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2011 Dec 19. [Epub ahead of print]
    PubMedGoogle Scholar
  • 52 Thomas DL, Astemborski J, Rai RM , et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284 (4) 450-456
    CrossrefPubMedGoogle Scholar
  • 53 Smukler AJ, Ratner L. Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Curr Opin Oncol 2002; 14 (5) 538-542
    CrossrefPubMedGoogle Scholar
  • 54 Bruno R, Gazzaruso C, Sacchi P , et al. High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J Acquir Immune Defic Syndr 2002; 31 (3) 363-365
    CrossrefPubMedGoogle Scholar
  • 55 Thio CL, Seaberg EC, Skolasky Jr R , et al; Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360 (9349) 1921-1926
    CrossrefPubMedGoogle Scholar
  • 56 Altavilla G, Caputo A, Lanfredi M, Piola C, Barbanti-Brodano G, Corallini A. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 2000; 157 (4) 1081-1089
    CrossrefPubMedGoogle Scholar
  • 57 Tanaka T, Imamura A, Masuda G , et al. A case of hepatocellular carcinoma in HIV-infected patient. Hepatogastroenterology 1996; 43 (10) 1067-1072
    PubMedGoogle Scholar
  • 58 Venkataramani M, Hutton N, Colombani P, Anders RA, Agwu AL. Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report. AIDS Patient Care STDS 2010; 24 (11) 693-696
    CrossrefPubMedGoogle Scholar
  • 59 Bruix J, Sherman M ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42 (5) 1208-1236
    CrossrefPubMedGoogle Scholar